SEARCH

SEARCH BY CITATION

References

  • Batista AM, Aguiar C, Almeida EA, Guariento ME, Wanderley JS & Costa SCB (2010) Evidence of Chagas disease in seronegative Brazilian patients with megaesophagus. International Journal of Infectious Diseases 14, 974977.
  • Britto C, Cardoso A, Silveira C, Macedo V & Fernandes O (1999) Polymerase chain reaction (PCR) as a laboratory tool for the evaluation of the parasitological cure in Chagas disease after specific treatment. Medicina (Buenos Aires) 59, 176178.
  • Chagas C (1909) Nova tripanozomiase humana: Estudos sobre a morfolojia e o ciclo evolutivo do Schizotrypanum cruzi n. gen., n. sp., ajente etiolojico de nova entidade morbida do homem. Memórias do Instituto Oswaldo Cruz 1, 159218.
  • Chiari E, Dias JCP, Lana M & Chiari CA (1989) Hemocultures for the parasitological diagnosis of human chronic Chagas disease. Revista da Sociedade Brasileira de Medicina Tropical 22, 1923.
  • Coura JR & Castro SL (2002) A critical review on Chagas disease chemotherapy. Memórias do Instituto Oswaldo Cruz 97, 324.
  • Fabbro DL, Streiger ML, Arias ED, Bizai ML, del Barco M & Amicone NA (2007) Trypanocide treatment among adults with chronic Chagas disease living in Santa Fe City (Argentina), over a mean follow-up of 21 years: parasitological, serological and clinical evolution. Revista da Sociedade Brasileira de Medicina Tropical 40, 110.
  • Fernandes CD, Tiecher FM, Balbinot MM et al. (2009) Efficacy of benznidazol treatment for asymptomatic chagasic patients from state of Rio Grande do Sul evaluated during a three years follow-up. Memórias do Instituto Oswaldo Cruz 104, 2732.
  • Flores-Chavez M, Bosseno MF, Bastrenta B et al. (2006) Polymerase chain reaction detection and serologic follow-up after treatment with benznidazole in Bolivian children infected with a natural mixture of Trypanosoma cruzi I and II. American Journal of Tropical Medicine and Hygiene 75, 497501.
  • Gallerano RR & Sosa RR (2000) Interventional study in the natural evolution of Chagas disease. Evaluation of specific antiparasitic treatment. Retrospective-prospective study of antiparasitic therapy. Revista de la Facultad de Ciencias Medicas da Universidad Nacional de Córdoba 57, 135162.
  • Gomes ML, Galvão LMC, Macedo AM, Pena SDJ & Chiari E (1999) Chagas disease diagnosis: comparative analysis of parasitologic, molecular, and serologic methods. The American Journal of Tropical Medicine and Hygiene 60, 205210.
  • Lacunza CD, Negrete OS, Mora MC et al. (2006) Use of the polymerase chain reaction (PCR) for early evaluation of etiological treatment in young adults, chronically infected with Trypanosoma cruzi. Revista da Patologia Tropical 35, 227232.
  • Lana M, Lopes LA, Martins HR et al. (2009) Clinical and laboratory status of patients with chronic Chagas disease living in a vector-controlled area in Minas Gerais, Brazil, before and nine years after aetiological treatment. Memórias do Instituto Oswaldo Cruz 104, 11391147.
  • Luz ZMP (1999) Changes in the hemoculture methodology improve the test positivity. Memórias do Instituto Oswaldo Cruz 94, 295298.
  • Marcon GEB, Andrade PD, de Albuquerque DM et al. (2002) Use of a nested polymerase chain reaction (N-PCR) to detect Trypanosoma cruzi in blood samples from chronic chagasic patients and patients with doubtful serologies. Diagnostic Microbiology and Infectious Diseases 43, 3943.
  • Marcon GEB, Albuquerque DM, Batista AM et al. (2011) Trypanosoma cruzi: parasite persistence in tissues in chronic chagasic Brazilian patients. Memórias do Instituto Oswaldo Cruz 106, 8591.
  • Marin-Neto JA, Rassi A Jr, Avezum A Jr, Mattos AC & Rassi A (2009) The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease. Memórias do Instituto Oswaldo Cruz 104, 319324.
  • Ministério da Saúde/Brasil (2005) Consenso Brasileiro em doença de Chagas. Revista da Sociedade Brasileira de Medicina Tropical 38 (Suppl. III), 129.
  • Moncayo A & Ortiz Yanine MI (2006) An update on Chagas disease (human American trypanosomiasis). Annals of Tropical Medicine & Parasitology 100, 663677.
  • Murcia L, Carrilero B, Muñoz MJ, Iborra MA & Segovia M (2010) Usefulness of PCR for monitoring benznidazole response in patients with chronic Chagas’ disease: a prospective study in a non-disease-endemic country. Journal of Antimicrobial Chemotherapy 65, 17591764.
  • PAHO/OMS (2009) Eliminação de doenças negligenciadas e outras infecções relacionadas à pobreza. Boletim Epidemiológico 28, Washington, DC. Available at: http://new.paho.org/bulletins/index2.php?option=com_content&do_pdf=1&id=565 (accessed 15 March 2011).
  • Portela-Lindoso AAB & Shikanai-Yasuda MA (2003) Doença de Chagas crônica: do xenodiagnóstico e hemocultura à reação em cadeia da polimerase. Revista de Saúde Pública 37, 107115.
  • Prata A (2001) Clinical and epidemiological aspects of Chagas disease. The Lancet Infectious Diseases 1, 92100.
  • Sambrook J & Russel DW (2001) In Molecular Cloning: A Laboratory Manual, 3rd edn. Cold Spring Harbor, New York, p. 2368.
  • Solari A, Ortíz S, Soto A et al. (2001) Treatment of Trypanosoma cruzi-infected children with nifurtimox: a 3 years follow-up by PCR. Journal of Antimicrobial Chemotherapy 48, 515519.
  • Urbina JA (1999) Chemotherapy of Chagas’ disease: the how and the why. Journal of Molecular Medicine 77, 332338.
  • Vago AR, Macedo AMM, Adad SJ, Reis DA & Corrêa-Oliveira R (1996) PCR detection of Trypanosoma cruzi DNA in oesophageal tissues of patients with chronic digestive Chagas’ disease. The Lancet 348, 891892.
  • Viotti R, Vigliano C, Armenti H & Segura E (1994) Treatment of chronic Chagas disease with benznidazole: clinical and serologic evolution of patients with long-term follow-up. American Heart Journal 127, 151162.